Robeauté raised $28 million in a Series A funding round led by Plural, Cherry Ventures, and Kindred Ventures to gain FDA approval for its microrobot designed for brain surgeries.

Jan 13, 2025•11 months ago

Amount Raised

$28 Million

Round Type

series a

ParisMedical DeviceMedicalBiotechnologyHealth Care

Investors

BrainlabApex VenturesThink.HealthLocal GlobeKindred VenturesCherry VenturesPlural

Description

Robeauté, a Paris-based startup, has secured $28 million in venture capital funding to develop a self-propelled microrobot aimed at assisting neurosurgeons. This funding will be used to obtain FDA approval for human clinical testing targeted for 2026.

Company Information

Company

Robeauté

Location

Paris, Ile De France, France

About

Robeauté is a Paris-based startup focused on developing self-propelled microrobots designed to operate within the human brain. Their primary goal is to assist neurosurgeons in procedures such as tissue sample collection for biopsies. The company aims to enable targeted delivery of cancer treatments and other therapeutic applications for various brain disorders. Founded in 2017, Robeauté combines advanced robotics with medical needs to create groundbreaking solutions in neurosurgery.

Related People

4 contacts

Funding Insights

Based on industry data

VC-backed spending patterns

VC-backed companies spend 89% more on sales and 100% more on marketing than bootstrapped peers

Tech investment trends